HIND — Vyome Holdings Share News
0.000.00%
Last trade - 00:00- $12.56m
- $5.94m
- $0.32m
Brief: Reshape Lifesciences® Engages Maxim Group Llc To Identify Strategic M&A Partnership Alternatives
U.S. STOCKS ON THE MOVE-Xpeng, Canopy Growth, ReShape Lifesciences
U.S. STOCKS ON THE MOVE-Southwest Airlines, Canopy Growth, US Steel
U.S. STOCKS ON THE MOVE-Vertex Pharma, Shattuck Labs, Airbnb
U.S. STOCKS ON THE MOVE-Pfizer, Tesla, Take-Two
ReShape Lifesciences jumps after modified obesity device gets FDA nod
Brief: Reshape Lifesciences Receives FDA PMA Supplement Approval For Lap-Band® 2.0 Flex
Brief: Reshape Lifesciences Enters Into Warrant Exercise Transaction For $1.2 Mln In Gross Proceeds
Brief: ReShape Lifesciences Q3 Net Income USD -3.534 Million
U.S. STOCKS ON THE MOVE-Microsoft, Gap, Alphabet
Brief: Reshape Lifesciences Received Notice From Nasdaq Indicating That Co Is Not In Compliance With $1.00 Minimum Bid Price Requirement
Brief: Reshape Lifesciences Announces Pricing Of $3.0 Million Public Offering
Brief: Reshape Lifesciences- On September 19, Co Entered Into Exclusive License Agreement With Biorad Medysis Pvt. Ltd.
Brief: Reshape Lifesciences Says License Agreement Provides $200,000 In Upfront Payments
Brief: Reshape Lifesciences Inc Files For Offering On Best Efforts Basis Up To 8.5 Million Units - SEC Filing
ReShape Lifesciences Inc reports results for the quarter ended in June - Earnings Summary
ReShape Lifesciences Inc expected to post a loss of $1.79 a share - Earnings Preview
Brief: ReShape Lifesciences Reports First Quarter 2023 Financial Results
ReShape Lifesciences Inc expected to post a loss of $4.21 a share - Earnings Preview